??-Fetoprotein and ??-Human Chorionic Gonadotropin
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 57 (4) , 463-467
- https://doi.org/10.2165/00003495-199957040-00001
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.Journal of Clinical Oncology, 1997
- Prognosis of intracranial germinoma with syncytiotrophoblastic giant cells treated by radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.Journal of Clinical Oncology, 1996
- Prognostic significance of Lens culinaris agglutinin A-reactive alpha- fetoprotein in small hepatocellular carcinomasGastroenterology, 1996
- Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survivalCancer, 1996
- Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.Journal of Clinical Oncology, 1995
- Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapyCancer, 1994
- SERUM TUMOR-MARKER HALF-LIFE DURING CHEMOTHERAPY ALLOWS EARLY PREDICTION OF COMPLETE RESPONSE AND SURVIVAL IN NONSEMINOMATOUS GERM-CELL TUMORS1990
- Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patientsCancer, 1989